ERBB2 and breast cancer: An evaluation of 50 ER/PR+, 34 HER2+, 24 ER/PR/HER+, 40 TNBC and 20 heathy breast cancer tissues showed a unique viral, bacterial, fungal, and parasitic signature between the sub-types [77].